메뉴 건너뛰기




Volumn 51, Issue 7, 2007, Pages 685-699

Potent CTL induction by a whole cell pertussis vaccine in anti-tumor peptide immunotherapy

Author keywords

Adjuvant; Immunotherapy; Peptide; Th1

Indexed keywords

ACELLULAR VACCINE; ARGINYLMETHIONYLPHENYLALANYLPROLYLASPARAGINYLALANYLPROLYLTYROSYLLEUCINE; GENE PRODUCT; OVALBUMIN; PEPTIDE; PERTUSSIS VACCINE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

EID: 34547118599     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03957.x     Document Type: Article
Times cited : (13)

References (62)
  • 1
    • 0031872473 scopus 로고    scopus 로고
    • Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens
    • Ausiello, C.M., Lande, R., la Sala, A., Urbani, F., and Cassone, A. 1998. Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens. J. Infect. Dis. 178: 466-470.
    • (1998) J. Infect. Dis , vol.178 , pp. 466-470
    • Ausiello, C.M.1    Lande, R.2    la Sala, A.3    Urbani, F.4    Cassone, A.5
  • 2
    • 0034131388 scopus 로고    scopus 로고
    • Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine
    • Ausiello, C.M., Lande, R., Urbani, F., Di Carlo, B., Stefanelli, P., Salmaso, S., Mastrantonio, P., and Cassone, A. 2000. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J. Infect. Dis. 181: 1989-1995.
    • (2000) J. Infect. Dis , vol.181 , pp. 1989-1995
    • Ausiello, C.M.1    Lande, R.2    Urbani, F.3    Di Carlo, B.4    Stefanelli, P.5    Salmaso, S.6    Mastrantonio, P.7    Cassone, A.8
  • 3
    • 0032769217 scopus 로고    scopus 로고
    • Cell-mediatd immune responses in four-year-old children after primary immunization with acellular pertussis vaccines
    • Ausiello, C.M., Lande, R., Urbani, F., la Sala, A., Stefanelli, P., Salmaso, S., Mastrantonio, P., and Cassone, A. 1999. Cell-mediatd immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect. Immun. 67: 4064-4071.
    • (1999) Infect. Immun , vol.67 , pp. 4064-4071
    • Ausiello, C.M.1    Lande, R.2    Urbani, F.3    la Sala, A.4    Stefanelli, P.5    Salmaso, S.6    Mastrantonio, P.7    Cassone, A.8
  • 4
    • 0030975947 scopus 로고    scopus 로고
    • Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines
    • Ausiello, C.M., Urbani, P., la Sala, A., Lande, R., and Cassone, A. 1997. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65: 2168-2174.
    • (1997) Infect. Immun , vol.65 , pp. 2168-2174
    • Ausiello, C.M.1    Urbani, P.2    la Sala, A.3    Lande, R.4    Cassone, A.5
  • 5
    • 0029875805 scopus 로고    scopus 로고
    • Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: Variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0
    • Barnard, A., Mahon, B.P., Watkins, J., Redhead, K., and Mills, K.H.G. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87: 372-380.
    • (1996) Immunology , vol.87 , pp. 372-380
    • Barnard, A.1    Mahon, B.P.2    Watkins, J.3    Redhead, K.4    Mills, K.H.G.5
  • 9
    • 33646400810 scopus 로고    scopus 로고
    • + T cells and monocyte/dendritic cell precursors. Cancer Res. 66: 4943-4950.
    • + T cells and monocyte/dendritic cell precursors. Cancer Res. 66: 4943-4950.
  • 13
    • 33750803442 scopus 로고    scopus 로고
    • Pertussis toxin in superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production
    • Fujimoto, C., Yu, C.-R., Shi, G., Vistica, B.P., Wawrousek, E.F., Klinman, D.M., Chan, C.-C., Egwuagu, C.E., and Gery, I. 2006. Pertussis toxin in superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. J. Immunol. 177: 6896-6903.
    • (2006) J. Immunol , vol.177 , pp. 6896-6903
    • Fujimoto, C.1    Yu, C.-R.2    Shi, G.3    Vistica, B.P.4    Wawrousek, E.F.5    Klinman, D.M.6    Chan, C.-C.7    Egwuagu, C.E.8    Gery, I.9
  • 14
    • 21344438670 scopus 로고    scopus 로고
    • Gerloni, M., and Zanetti, M. 2005. CD4 T cells in tumor immunity. Springer Semin. Immun. 27: 37-48.
    • Gerloni, M., and Zanetti, M. 2005. CD4 T cells in tumor immunity. Springer Semin. Immun. 27: 37-48.
  • 15
    • 0018871806 scopus 로고
    • Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines
    • Gillis, S., Smith, K.A., and Watson, J. 1980. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J. Immunol. 124: 1954-1962.
    • (1980) J. Immunol , vol.124 , pp. 1954-1962
    • Gillis, S.1    Smith, K.A.2    Watson, J.3
  • 16
    • 0020623652 scopus 로고
    • The major histocompatibility complex-restricted anigen receptor on T cells
    • Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J., and Marrack, P. 1983. The major histocompatibility complex-restricted anigen receptor on T cells. J. Exp. Med. 157: 1149-1169.
    • (1983) J. Exp. Med , vol.157 , pp. 1149-1169
    • Haskins, K.1    Kubo, R.2    White, J.3    Pigeon, M.4    Kappler, J.5    Marrack, P.6
  • 21
    • 0025916364 scopus 로고
    • Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse Vbeta5 T cell receptor for antigen determinants
    • Kanagawa, O., Utsunomiya, Y., Bill, J., Palmer, E., Moore, M.W., and Carbone, F.R. 1991. Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse Vbeta5 T cell receptor for antigen determinants. J. Immunol. 147: 1307-1314.
    • (1991) J. Immunol , vol.147 , pp. 1307-1314
    • Kanagawa, O.1    Utsunomiya, Y.2    Bill, J.3    Palmer, E.4    Moore, M.W.5    Carbone, F.R.6
  • 22
    • 33747772051 scopus 로고    scopus 로고
    • T helper lymphocytes rescue CTL from activation-induced cell death
    • Kennedy, R., and Celis, E. 2006. T helper lymphocytes rescue CTL from activation-induced cell death. J. Immunol. 177: 2862-2872.
    • (2006) J. Immunol , vol.177 , pp. 2862-2872
    • Kennedy, R.1    Celis, E.2
  • 23
    • 0032482274 scopus 로고    scopus 로고
    • Licence to kill
    • Lanzavecchia, A. 1998. Licence to kill. Nature 393: 413-414.
    • (1998) Nature , vol.393 , pp. 413-414
    • Lanzavecchia, A.1
  • 24
    • 0036629799 scopus 로고    scopus 로고
    • Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen
    • Lavigne, M., Castro, M., Mateo, N., Deluchi, S., Atzori, C., Piudo, L., Calcagno, M., Brero, M., and Manghi, M. 2002. Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen. Microbes Infect. 4: 815-820.
    • (2002) Microbes Infect , vol.4 , pp. 815-820
    • Lavigne, M.1    Castro, M.2    Mateo, N.3    Deluchi, S.4    Atzori, C.5    Piudo, L.6    Calcagno, M.7    Brero, M.8    Manghi, M.9
  • 25
    • 1942452800 scopus 로고    scopus 로고
    • Alternative diphtheria, tetanus and shooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response
    • Lavigne, M.V., Castro, M., Andino, J., and Manghi, M. 2004. Alternative diphtheria, tetanus and shooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response. Microbes Infect. 6: 481-484.
    • (2004) Microbes Infect , vol.6 , pp. 481-484
    • Lavigne, M.V.1    Castro, M.2    Andino, J.3    Manghi, M.4
  • 26
    • 0029834751 scopus 로고    scopus 로고
    • Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis vaccine by promoting induction of Th1 cells
    • Mahon, B.P., Ryan, M.S., Griffin, F., and Mills, K.H.G. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64: 5295-5301.
    • (1996) Infect. Immun , vol.64 , pp. 5295-5301
    • Mahon, B.P.1    Ryan, M.S.2    Griffin, F.3    Mills, K.H.G.4
  • 28
    • 0033105362 scopus 로고    scopus 로고
    • T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors
    • Marzo, A.L., Lake, R.A., Robinson, B.W.S., and Scott, B. 1999. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Cancer Res. 59: 1071-1079.
    • (1999) Cancer Res , vol.59 , pp. 1071-1079
    • Marzo, A.L.1    Lake, R.A.2    Robinson, B.W.S.3    Scott, B.4
  • 29
    • 0034974006 scopus 로고    scopus 로고
    • Immunity to Bordetella pertussis
    • Mills, K.H.G. 2001. Immunity to Bordetella pertussis. Microbes Infect. 3: 655-677.
    • (2001) Microbes Infect , vol.3 , pp. 655-677
    • Mills, K.H.G.1
  • 30
    • 0023821578 scopus 로고
    • Introduction of soluble protein into the class I pathway of antigen processing and presentation
    • Moore, M.W., Carbone, F.R., and Bevan, M.J. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
    • (1988) Cell , vol.54 , pp. 777-785
    • Moore, M.W.1    Carbone, F.R.2    Bevan, M.J.3
  • 31
    • 21344459458 scopus 로고    scopus 로고
    • Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results
    • Mosolits, S., Ullenhag, G., and Mellstedt, H., 2005. Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results. Ann. Oncol. 16: 847-862.
    • (2005) Ann. Oncol , vol.16 , pp. 847-862
    • Mosolits, S.1    Ullenhag, G.2    Mellstedt, H.3
  • 35
    • 33744815600 scopus 로고    scopus 로고
    • Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer
    • Nagorsen, D., and Thiel, E. 2006. Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer. Clin. Cancer Res. 12: 3064-3069.
    • (2006) Clin. Cancer Res , vol.12 , pp. 3064-3069
    • Nagorsen, D.1    Thiel, E.2
  • 39
    • 4644289323 scopus 로고    scopus 로고
    • Oka, Y., Tsuboi, A., Taguchi, T., Osaki, T., Kyo, T., Nakajima, H., Elisseeva, O.A., Oji, Y., Kawakami, M., Ikegami, K., Hosen, N., Yoshihara, S., Wu, F., Fujiki, F., Murakami, M., Masuda, T., Nishida, S., Shirakata, T., Nakatsuka, S., Sasaki, A., Udaka, K., Dohy, H., Aozasa, K., Noguchi, S., Kawase, I., and Sugiyama, H. 2004. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc. Natl. Acad. Sci. U.S.A. 101: 13885-13890.
    • Oka, Y., Tsuboi, A., Taguchi, T., Osaki, T., Kyo, T., Nakajima, H., Elisseeva, O.A., Oji, Y., Kawakami, M., Ikegami, K., Hosen, N., Yoshihara, S., Wu, F., Fujiki, F., Murakami, M., Masuda, T., Nishida, S., Shirakata, T., Nakatsuka, S., Sasaki, A., Udaka, K., Dohy, H., Aozasa, K., Noguchi, S., Kawase, I., and Sugiyama, H. 2004. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc. Natl. Acad. Sci. U.S.A. 101: 13885-13890.
  • 42
    • 0037811736 scopus 로고    scopus 로고
    • Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human Interleukin-12 induces clinical activity and T-cell responses in advanced melanoma
    • Peterson, A., Harlin, H., and Gajewski, T. 2006. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human Interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J. Clin. Oncol. 21: 2342-2348.
    • (2006) J. Clin. Oncol , vol.21 , pp. 2342-2348
    • Peterson, A.1    Harlin, H.2    Gajewski, T.3
  • 43
    • 19544363581 scopus 로고    scopus 로고
    • PTX cruiser: Driving autoimmunity via TLR4
    • Racke, M.K., Hu, W., and Lovett-Racke, A.M. 2005. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol. 26: 289-291.
    • (2005) Trends Immunol , vol.26 , pp. 289-291
    • Racke, M.K.1    Hu, W.2    Lovett-Racke, A.M.3
  • 44
    • 0027198942 scopus 로고
    • Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity
    • Readhead, K., Watkins, J., Barnard, A., and Mills, K.H.G. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61: 3190-3198.
    • (1993) Infect. Immun , vol.61 , pp. 3190-3198
    • Readhead, K.1    Watkins, J.2    Barnard, A.3    Mills, K.H.G.4
  • 45
    • 33645088927 scopus 로고    scopus 로고
    • Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: A comparison with data from clinical study
    • Reynolds, E., Walker, B., Xing, D., Southern, J., Asokanathan, C., Dagg, B., Corbel, M., and Miller, E. 2006. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study. Vaccine 24: 3248-3257.
    • (2006) Vaccine , vol.24 , pp. 3248-3257
    • Reynolds, E.1    Walker, B.2    Xing, D.3    Southern, J.4    Asokanathan, C.5    Dagg, B.6    Corbel, M.7    Miller, E.8
  • 47
    • 0036087959 scopus 로고    scopus 로고
    • Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: Evidence for early control of pertussis
    • Roduit, C., Bozzotti, P., Mielcarek, N., Lambert, P.-H., del Giudice, G., Locht, C., and Siegrist, C.A. 2002. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect. Immun. 70: 3521-3528.
    • (2002) Infect. Immun , vol.70 , pp. 3521-3528
    • Roduit, C.1    Bozzotti, P.2    Mielcarek, N.3    Lambert, P.-H.4    del Giudice, G.5    Locht, C.6    Siegrist, C.A.7
  • 48
    • 1542327598 scopus 로고    scopus 로고
    • Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination
    • Romero, P., Cerottini, J.-C., and Speiser, D.E. 2004. Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination. Cancer Immunol. Immunother. 53: 249-255.
    • (2004) Cancer Immunol. Immunother , vol.53 , pp. 249-255
    • Romero, P.1    Cerottini, J.-C.2    Speiser, D.E.3
  • 50
    • 4644324025 scopus 로고    scopus 로고
    • Cancer immunotherapy: Moving beyond current vaccines
    • Rosenberg, S.A., Yang, J.C., and Restifo, N.P. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915.
    • (2004) Nat. Med , vol.10 , pp. 909-915
    • Rosenberg, S.A.1    Yang, J.C.2    Restifo, N.P.3
  • 53
    • 0037432787 scopus 로고    scopus 로고
    • Requirement for CD4 T cell help in generating functional CD8 T cell memory
    • Shedlock, D.J., and Shen, H. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
    • (2003) Science , vol.300 , pp. 337-339
    • Shedlock, D.J.1    Shen, H.2
  • 54
    • 0642311904 scopus 로고    scopus 로고
    • Slingluff, C.L., Petroni, G.R., Yamshchikov, G.V., Barnd, D.L., Eastham, S., Galavotti, H., Patterson, J.W., Deacon, D.H., Hibbitts, S., Teates, D., Neese, P.Y., Grosh, W.W., Chianese-Bullock, K.A., Woodson, E.M.H., Wiernasz, C.J., Merrill, P., Gibson, J., Ross, M., and Engelhard, V.H. 2006. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J. Clin. Oncol. 21: 4016-4026.
    • Slingluff, C.L., Petroni, G.R., Yamshchikov, G.V., Barnd, D.L., Eastham, S., Galavotti, H., Patterson, J.W., Deacon, D.H., Hibbitts, S., Teates, D., Neese, P.Y., Grosh, W.W., Chianese-Bullock, K.A., Woodson, E.M.H., Wiernasz, C.J., Merrill, P., Gibson, J., Ross, M., and Engelhard, V.H. 2006. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J. Clin. Oncol. 21: 4016-4026.
  • 57
    • 0027234521 scopus 로고
    • Collaboration of helper and cytotoxic T lymphocytes
    • Stuhler, G., and Walden, P. 1993. Collaboration of helper and cytotoxic T lymphocytes. Eur. J. Immunol. 23: 2279-2286.
    • (1993) Eur. J. Immunol , vol.23 , pp. 2279-2286
    • Stuhler, G.1    Walden, P.2
  • 59
    • 0033405438 scopus 로고    scopus 로고
    • Thurner, B., Haendle, I., Roeder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., Broecker, E.B., Steinman, R.M., Enk, A., Kaempgen, E., and Schuler, G. 1999. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669-1678.
    • Thurner, B., Haendle, I., Roeder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., Broecker, E.B., Steinman, R.M., Enk, A., Kaempgen, E., and Schuler, G. 1999. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669-1678.
  • 60
    • 0029798058 scopus 로고    scopus 로고
    • Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction
    • Toes, R.E.M., Offringa, R., Blom, R.J.J., Melief, C.J.M., and Kast, W.M. 1996. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl. Acad. Sci. U.S.A. 93: 7855-7860.
    • (1996) Proc. Natl. Acad. Sci. U.S.A , vol.93 , pp. 7855-7860
    • Toes, R.E.M.1    Offringa, R.2    Blom, R.J.J.3    Melief, C.J.M.4    Kast, W.M.5
  • 62
    • 0034440543 scopus 로고    scopus 로고
    • Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults
    • Weingart, C.L., Keitel, W.A., Edwards, K.M., and Weiss, A.A. 2000. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect. Immun. 68: 7175-7179.
    • (2000) Infect. Immun , vol.68 , pp. 7175-7179
    • Weingart, C.L.1    Keitel, W.A.2    Edwards, K.M.3    Weiss, A.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.